Treatment of periodontal disease in diabetics reduces glycated hemoglobin

Journal of Periodontology

Volumn 68, Issue 8, 1997, Pages 713-719

  Grossi, Sara G ^a   Skrepcinski, Fred B ^b   DeCaro, Thomas ^b   Robertson, Don C ^b   Ho, Alex W ^a   Dunford, Robert G ^a   Genco, Robert J ^a  

^a School of Dental Medicine at SUNY   (United States)

^b U S PUBLIC HEALTH SERVICE   (United States)

Author keywords

Chlorhexidine therapeutic use; Diabetes mellitus; Doxycycline therapeutic use; Non insulin dependent epidemiology; Periodontal diseases therapy; Porphyromonas gingivalis; Povidone iodine therapeutic use

Indexed keywords

CHLORHEXIDINE; DOXYCYCLINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; POVIDONE IODINE;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTAL DISEASE; PORPHYROMONAS; TOPICAL DRUG ADMINISTRATION;

EID: 0030746716     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1997.68.8.713     Document Type: Article

References (23)

1. Clark CM, Lee DA. Prevention and treatment of the complications of diabetes. N Engl J Med 1995;32(18):1210-1217.
2. Williams R, Mahan C. Periodontal disease and diabetes in young adults. JAMA 1960;172:776-778.
3. Miller LS, Manwell, MA, Newbold D, et al. The relationship between reduction in periodontal inflammation and diabetes control: A report of 9 cases. J Periodontol 1992;63:843-848.
4. Knowler WC, Bennett PH, Hamman RF et al. Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 1978;108:497-505.
5. Shlossman M, Knowler WC, Pettitt DJ, et al. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc 1990;121:532-536.
6. Nelson RG, Shlossman M, Budding L, et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990;13:836-840.
7. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in noninsulin dependent diabetes mellitus. J Periodontol 1991;62:123-130.
8. World Health Organization, Expert Committee on Diabetes. Second Report 1980. Technical Report Service No. 646, Geneva.
9. Rosling BG, Slots J, Christersson LA, Grondahl HG, Genco RJ. Topical antimicrobial therapy and diagnosis of subgingival bacteria in the management of inflammatory periodontal disease. J Clin Periodontol 1986;13:975-981.
10. Machtei EE, Christersson LA, Grossi SG, Dunford R, Zambon JJ, Genco RJ. Clinical criteria for the definition of "established periodontitis." J Periodontol 1992;63:207-215.
11. Cohen DW, Freidman LA, Shapiro J, Kyle GC, Franklin S. Diabetes mellitus in periodontal disease: Two-year longitudinal observations. J Periodontol 1970;41:709-712.
12. Sastrowijoto SH, van der Velden U, van Steenbergen TJM, et al. Improved metabolic control, clinical periodontal status and subgingival microbiology in insulin-dependent mellitus. A prospective study. J Clin Periodontol 1990;17:233-242.
13. Weslfelt E, Rylander H, Blohmé G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol 1996;23:92-100.
14. Yki-Järvinen H, Sammalkorpi K, Koivisto VA, Nikkilä EA. Severity, duration and mechanisms of insulin resistance during acute infections. J Clin Endocrinol Metab 1989;69:317-323.
15. Ryan M, Ramamurthy N, Golub LM. Six CMT's modulate MMPs and non-enzymatic glycosylation in diabetic rats. J Dent Res 1995; 74(Spec. Issue):138(Abstr. 1010).
16. Sorsa T, Ingman T, Suomalainen K, et al. Cellular source and tetracycline-inhibition of gingival crevicular fluid collagenase of patients with labile diabetes mellitus. J Clin Periodontol 1992;19:146-149.
17. Lauhio A, Sorsa T, Lindy O, et al. The anticollagenolytic potential of tetracycline in long-term treatment of reactive arthritis. Arthritis Rheumatism 1992;35:195-198.
18. Ramamurthy NS, Vernillo AT, Greenwald RA, Lee HM, Sorsa T, Golub LM. Reactive oxygen species activate and tetracycline inhibits rat osteoblast collagenase. J Bone Min Res 1993;8:1247-1253.
19. Sorsa T, Lindy O, Konttinen YT, et al. Doxycycline in the protection of serum alpha-1-antitrypsin from human neutroplil collagenase and gelatinase. Antimicrob Agents Chemother 1993;36:227-229.
20. Hanemaaijer R, Visser H, Koolwijk T, et al. Down-regulation of gelatinase B activity and synthesis by doxycycline in human endothelial cells. J Dent Res 1996;75(Spec. Issue):107(Abstr. 716).
21. Lauhio A, Salo T, Tjaderhane L, Lahdervita J, Golub LM, Sorsa T. Tetracyclines in treatment of rheumatoid arthritis. Lancet 1995;346: 645-646.
22. Sasaki T, Ramamurthy NS, Yu Z, Golub LM. Tetracycline administration increases protein (presumably procollagen) synthesis and secretion in periodontal ligament fibroblasts of streptozotocin-induced diabetic rats. J Periodont Res 1992;27:631-639.
23. Rifkin BR, Vernillo AT, Golub LM. Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs. J Periodontol 1993;64:819-827.